Home 2023

Ophthalmic diseases

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar
GEN Edge

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar

Alex Philippidis -
0
On Your Mark: ALSA Ventures Lifts Early-Stage European Biotechs to Jockey Out of the Gate
Drug Discovery

On Your Mark: ALSA Ventures Lifts Early-Stage European Biotechs to Jockey Out of the Gate

Jonathan D Grinstein, PhD -
0
StockWatch: Short Seller Briefly Dents Apellis Shares
GEN Edge

StockWatch: Short Seller Briefly Dents Apellis Shares

Alex Philippidis -
0
Apellis Axing 25% of Staff, Shifting Resources to GA Drug
Drug Discovery

Apellis Axing 25% of Staff, Shifting Resources to GA Drug

Alex Philippidis -
0
Novel Therapeutic Model Created to Study Eye Diseases
News

Novel Therapeutic Model Created to Study Eye Diseases

Christina Jackson -
0
Astellas to Acquire Iveric Bio for $5.9B, Expanding Eye Disease Pipeline
Drug Discovery

Astellas to Acquire Iveric Bio for $5.9B, Expanding Eye Disease Pipeline

Alex Philippidis -
0
Genetic Variant Linked with Severe Manifestation of Crohn’s Disease
Featured

Genetic Variant Linked with Severe Manifestation of Crohn’s Disease

Sophia Ktori -
0
Extremely Rare Genetic Variants Implicated in Cause of Age-Related Macular Degeneration
Featured

Extremely Rare Genetic Variants Implicated in Cause of Age-Related Macular Degeneration

Sophia Ktori -
0
Prime Editing Reverses Vision Loss in Mice
News

Prime Editing Reverses Vision Loss in Mice

Julianna LeMieux, PhD -
0
Removing Senescent Cells May Slow, Halt, or Reverse Diseases of Aging
Drug Discovery

Removing Senescent Cells May Slow, Halt, or Reverse Diseases of Aging

Jonathan D Grinstein, PhD -
0
123...41Page 1 of 41
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.